Previous 10 | Next 10 |
home / stock / vvcif / vvcif news
Cannabidiol (CBD) is, without a doubt, one of the most potent and versatile medicines we have come across in recent times. It has more uses than most pharmaceuticals, and it is easier on the body too. The cannabis extract has proven effective against a variety of medical conditions ranging fro...
VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF) , an Ontario-based cannabis company recognized for its premium products and services, has entered into a technology and multi-phase research agreement with CB2 Insights Inc. (CSE: CBII) (OTCQB: CBIIF) ("CB2"), a leading data-driven company focused on...
VIVO and CB2 Insights Enter Technology and Research Partnership Canada NewsWire TORONTO, Oct. 29, 2019 Partnership to focus on implementing a medical product development strategy for VIVO's global medical cannabis offering, utilizing CB2 Insights' leading technology platfor...
The lawmakers in Connecticut have allowed more medical marijuana qualifying conditions. On Tuesday, the General Assembly Regulations Review Committee added five qualifying conditions for adults. Two of the five conditions are intractable neuropathic pain and Tourette syndrome. Patients under t...
The cannabis plant is famous mostly for producing THC, the compound responsible for cannabis’s psychotropic high, and cannabidiol (CBD), the primary non-psychoactive agent in the cannabis plant. CBD has earned a name for itself over the years as a versatile, efficient solution to a vari...
On Monday, Scott Gottlieb, the former Food and Drug Administration Commissioner, said that the federal government should be given the authority to regulate states’ marijuana programs. In a CNBC appearance, Scott Gottlieb said that the increase in vaping related lung illnesses calls fo...
Cannabidiol is one of the most controversial medical treatments of the decade. While plenty of people swear that they experienced varied health benefits after using CBD, some are more cynical, citing a lack of scientific research on the efficacy and side effects of the cannabinoid. Indeed, the...
VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) this morning announced its expected commencement of the first harvest at its Kimmetts facility in Napanee, Ontario in the fourth quarter of 2019. In addition, VIVO unveiled its plans for the facility in 2020, which include an accelerated planti...
VIVO Cannabis™ Reaffirms Timing of First Harvest at Kimmetts and Additional 2020 Cultivation Plans Canada NewsWire NAPANEE, ON, Oct. 3, 2019 Announcements made during VIVO's Analyst and Investor Day Held at Napanee Operations NAPANEE, ON , Oct. 3, 2019 /CNW/ ...
In 2013, Phoenix New Times published an article showing people the step by step process of getting their Arizona Medical Marijuana Card. After August 27 of 2019, a new law signed by Governor Doug of Arizona allows patients, caregivers and pharmacy agents to access the medical marijuana card at...
News, Short Squeeze, Breakout and More Instantly...
MediPharm Labs Corp. Completes Acquisition of VIVO Cannabis Inc. and Confirms Final Ownership Ratio Canada NewsWire BARRIE, ON , April 3, 2023 /CNW/ - MediPharm Labs Corp . (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", or "MediPharm Labs") and VIVO Ca...
Net revenue for Q4 2022 was $7.1 million, a 15% increase from prior quarter. Net revenue for 2022 was $25.4 million, a 2% increase compared to 2021. Net losses have decreased by 21.2 million in 2022, a 30% decrease from the prior year. The Company signed a definitive agreemen...
Toronto, Ontario--(Newsfile Corp. - March 24, 2023) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) (" VIVO ") is pleased to announce that it has obtained a final court order (the " Final Order ") from the Ontario Superior Court of Justice (Commercial List) approving the previously announced pl...